ArticleFrontiers in genetics2022

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer.

Mengjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.